Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- Researchers Examine the Persistence of Invisible Plastic Pollution.
- Rutgers Health Officials Celebrate $47.5 Million Grant to Improve Health Care in New Jersey.
- NJACTS Community Engagement Core Available Services
- New Model Identifies Best Candidates for Epilepsy Surgery.
- Study Finds Telehealth Effective for HIV Patients.
Categories
- Community (2,050)
- Covid (978)
- CTO Events (4)
- News (2,604)
- Pilots (20)